ITMI20042189A1 - Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale - Google Patents

Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale

Info

Publication number
ITMI20042189A1
ITMI20042189A1 IT002189A ITMI20042189A ITMI20042189A1 IT MI20042189 A1 ITMI20042189 A1 IT MI20042189A1 IT 002189 A IT002189 A IT 002189A IT MI20042189 A ITMI20042189 A IT MI20042189A IT MI20042189 A1 ITMI20042189 A1 IT MI20042189A1
Authority
IT
Italy
Prior art keywords
probiotic bacteria
prevention
improvement
treatment
pathologies
Prior art date
Application number
IT002189A
Other languages
English (en)
Inventor
Giovanni Mogna
Gian Paolo Strozzi
Original Assignee
Anidral Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35677517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI20042189(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Anidral Srl filed Critical Anidral Srl
Priority to IT002189A priority Critical patent/ITMI20042189A1/it
Publication of ITMI20042189A1 publication Critical patent/ITMI20042189A1/it
Priority to KR1020077011176A priority patent/KR101228608B1/ko
Priority to JP2007542140A priority patent/JP2008520640A/ja
Priority to PT05793656T priority patent/PT1773361E/pt
Priority to CN2005800327953A priority patent/CN101031313B/zh
Priority to DK05793656.9T priority patent/DK1773361T4/da
Priority to DE602005015451T priority patent/DE602005015451D1/de
Priority to EP05793656A priority patent/EP1773361B2/en
Priority to RU2007106038/10A priority patent/RU2418063C2/ru
Priority to US11/719,027 priority patent/US9233130B2/en
Priority to BRPI0517273A priority patent/BRPI0517273B8/pt
Priority to PL05793656T priority patent/PL1773361T5/pl
Priority to PCT/IB2005/003214 priority patent/WO2006054135A1/en
Priority to ES05793656T priority patent/ES2329390T5/es
Priority to HK08101361.1A priority patent/HK1110510A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT002189A 2004-11-16 2004-11-16 Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale ITMI20042189A1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT002189A ITMI20042189A1 (it) 2004-11-16 2004-11-16 Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
PCT/IB2005/003214 WO2006054135A1 (en) 2004-11-16 2005-10-05 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
ES05793656T ES2329390T5 (es) 2004-11-16 2005-10-05 Composición a base de bacterias probióticas y uso de la misma en prevención y/o el tratamiento de infecciones y/o patologías respiratorias y en la mejora de la funcionalidad intestinal
DK05793656.9T DK1773361T4 (da) 2004-11-16 2005-10-05 Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
RU2007106038/10A RU2418063C2 (ru) 2004-11-16 2005-10-05 Композиция на основе пробиотических бактерий и ее применение в профилактике и/или лечении респираторных патологий и/или инфекций и в улучшении функции кишечника
PT05793656T PT1773361E (pt) 2004-11-16 2005-10-05 Composição baseada em bactérias probióticas e sua utilização na prevenção e/ou tratamento de patologias e/ou infecções respiratórias e na melhoria da funcionalidade intestinal
CN2005800327953A CN101031313B (zh) 2004-11-16 2005-10-05 基于益生菌的组合物及其在预防和/或治疗呼吸性病变和/或感染以及改善肠功能中的用途
KR1020077011176A KR101228608B1 (ko) 2004-11-16 2005-10-05 프로바이오틱 박테리아 기초 조성물 및 호흡기 병리 및/또는 감염의 예방 및/또는 치료 및 장 기능성 개선에 있어서 그들의 용도
DE602005015451T DE602005015451D1 (de) 2004-11-16 2005-10-05 Auf probiotischen bakterien basierende zusammensetzung und ihre verwendung zur vorbeugung und/oder behandlung von atemwegserkrankungen und/oder infektionen sowie zur verbesserung der darmtätigkeit
EP05793656A EP1773361B2 (en) 2004-11-16 2005-10-05 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
JP2007542140A JP2008520640A (ja) 2004-11-16 2005-10-05 プロバイオティクス細菌系組成物、ならびに、呼吸病態および／または呼吸器系感染の予防および／または治療、および腸機能改善へのその使用
US11/719,027 US9233130B2 (en) 2004-11-16 2005-10-05 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
BRPI0517273A BRPI0517273B8 (pt) 2004-11-16 2005-10-05 composição contendo uma mistura de três bactérias probióticas, uso desta para a prevenção e/ou tratamento de infecções do trato respiratório superior e na regularização da funcionalidade intestinal do organismo acometido por essas patologias e kit contendo uma mistura de três bactérias probióticas
PL05793656T PL1773361T5 (pl) 2004-11-16 2005-10-05 Kompozycje oparte na bakteriach probiotycznych i ich zastosowanie w profilaktyce i/lub leczeniu patologii i/lub zakażeń układu oddechowego oraz poprawie funkcji jelit
HK08101361.1A HK1110510A1 (en) 2004-11-16 2008-02-05 Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002189A ITMI20042189A1 (it) 2004-11-16 2004-11-16 Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale

Publications (1)

Publication Number Publication Date
ITMI20042189A1 true ITMI20042189A1 (it) 2005-02-16

Family

ID=35677517

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002189A ITMI20042189A1 (it) 2004-11-16 2004-11-16 Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale

Country Status (15)

Country Link
US (1) US9233130B2 (it)
EP (1) EP1773361B2 (it)
JP (1) JP2008520640A (it)
KR (1) KR101228608B1 (it)
CN (1) CN101031313B (it)
BR (1) BRPI0517273B8 (it)
DE (1) DE602005015451D1 (it)
DK (1) DK1773361T4 (it)
ES (1) ES2329390T5 (it)
HK (1) HK1110510A1 (it)
IT (1) ITMI20042189A1 (it)
PL (1) PL1773361T5 (it)
PT (1) PT1773361E (it)
RU (1) RU2418063C2 (it)
WO (1) WO2006054135A1 (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115025132A (zh) * 2022-06-09 2022-09-09 康永波 一种合生元组合物及其制备方法和应用

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
WO2008042101A2 (en) * 2006-10-02 2008-04-10 Danisco A/S Probiotics for use in reducing the incidence and duration of illness
JP5689601B2 (ja) * 2006-12-11 2015-03-25 デュポン ニュートリション バイオサイエンシーズ エーピーエス 組成物
CA2695366C (en) * 2007-08-03 2016-10-04 Shaklee Corporation Nutritional supplement system
US9763989B2 (en) 2007-08-03 2017-09-19 Shaklee Corporation Nutritional supplement system
WO2009021585A1 (en) * 2007-08-13 2009-02-19 Dsm Ip Assets B.V. Probiotic bacteria for rducing the occurence of symptoms of winter infections
ES2399775T3 (es) * 2007-10-11 2013-04-03 Dupont Nutrition Biosciences Aps Composiciones farmacéuticas que comprenden L. acidophilus y bifidobacterium lactis para el uso en el tratamiento de un trastorno intestinal funcional
ITMI20072260A1 (it) 2007-12-03 2009-06-04 Anidral Srl Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.
US20090280099A1 (en) * 2008-05-07 2009-11-12 Bachman Stephen E Nasopharyngeal inoculate of probiotics and prebiotics for treatment of respiratory infections
JP5426850B2 (ja) * 2008-08-19 2014-02-26 株式会社日清製粉グループ本社 インフルエンザワクチンのアジュバント
KR101001767B1 (ko) 2008-11-04 2010-12-15 주식회사한국야쿠르트 항 인플루엔자 바이러스 효능을 갖는 락토바실러스 루테리 에이취와이7501 및 이를 유효성분으로 함유하는 제품
US20110256179A1 (en) * 2008-11-17 2011-10-20 Essum Ab Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
PL2435554T3 (pl) 2009-05-26 2018-01-31 Advanced Bionutrition Corp Stabilna kompozycja suchego proszku zawierająca biologicznie aktywne mikroorganizmy i/lub materiały bioaktywne i sposoby jej wykonania
IT1397566B1 (it) * 2009-05-27 2013-01-16 Probiotical Spa Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
WO2011044934A1 (en) * 2009-10-14 2011-04-21 Probiotical S.P.A Probiotic bacteria strains enabling of hydrolyzing prebiotic fibers and symbiotic compositions thereof
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
FI20096400A0 (fi) * 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö I
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
SG182317A1 (en) 2010-01-28 2012-08-30 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
WO2011148219A1 (en) * 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
CL2010001124A1 (es) * 2010-10-14 2011-01-21 Univ De Concepcion 50% Ma Loreto Ormeno 50% Alimento funcional probiotico que comprende cepas viables de lactobacillus sp.; uso de dicho alimento funcional para contrarestar los efectos colaterales de la quimioterapia.
GB201110095D0 (en) * 2011-06-15 2011-07-27 Danisco Method of treatment
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
ITRM20110475A1 (it) * 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITRM20110477A1 (it) * 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US9642883B2 (en) 2012-01-13 2017-05-09 Chr. Hansen A/S Lactobacillus rhamnosus and Bifidobacterium animalis subsp. lactis for use in prevention or treatment of upper respiratory tract infections
KR101381794B1 (ko) * 2012-04-10 2014-04-07 씨제이제일제당 (주) 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물
KR101398977B1 (ko) * 2012-11-14 2014-05-27 대구가톨릭대학교산학협력단 락토바실러스 카세이 유산균주 배양용 d-타가토오스 함유 배지 및 d-타가토오스첨가 요구르트의 제조방법
JP6349262B2 (ja) * 2013-01-31 2018-06-27 国立大学法人 香川大学 血糖値の上昇抑制効果を有するこんにゃく加工飲食品
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN104957260B (zh) * 2014-03-07 2018-07-24 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
SG10202105996WA (en) 2014-12-23 2021-07-29 4D Pharma Res Ltd Pirin polypeptide and immune modulation
KR20220151045A (ko) 2014-12-23 2022-11-11 4디 파마 리서치 리미티드 면역 조정
MD3240554T2 (ro) 2015-06-15 2020-01-31 4D Pharma Res Ltd Blautia stercosis și wexlerae pentru utilizare în tratarea bolilor inflamatorii și autoimune
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3206700T3 (pl) 2015-06-15 2019-11-29 4D Pharma Res Ltd Kompozycje zawierające szczepy bakteryjne
RS59308B1 (sr) 2015-06-15 2019-10-31 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN105055438A (zh) * 2015-07-21 2015-11-18 珲春市神怡菌业生物科技开发有限公司 一种具有改善胃肠道功能的香菇多糖益生元组合物
CA2994112C (en) 2015-07-29 2023-08-08 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
ITUB20153106A1 (it) * 2015-08-13 2017-02-13 Probiotical Spa Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
ME03003B (me) 2015-11-20 2018-10-20 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
ITUB20159330A1 (it) 2015-12-22 2017-06-22 Roelmi Hpc S R L Composizioni probiotiche e loro uso
KR101749222B1 (ko) * 2016-01-04 2017-06-21 주식회사 카브 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물
RS58869B1 (sr) 2016-03-04 2019-08-30 4D Pharma Plc Kompozicije koje sadrže blautia bakterijske sojeve za lečenje visceralne hipersenzitivnosti
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
CN106177188A (zh) * 2016-08-02 2016-12-07 马南行 一种用于女性抑菌平衡的益生菌组合物及其制备方法
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018125735A1 (en) * 2016-12-29 2018-07-05 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
TWI787272B (zh) 2017-05-22 2022-12-21 英商4D製藥研究有限公司 包含細菌菌株之組合物
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
JP6884889B2 (ja) 2017-06-14 2021-06-09 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
KR20200015575A (ko) 2017-06-14 2020-02-12 4디 파마 리서치 리미티드 세균 균주를 포함하는 조성물
CN108295098A (zh) * 2018-02-02 2018-07-20 云南中京国建投资有限公司 一种辅助降血糖的合生元组合物及其制剂与应用
WO2019227414A1 (zh) * 2018-05-31 2019-12-05 深圳华大生命科学研究院 一种组合物及其应用
KR101932955B1 (ko) 2018-06-14 2018-12-27 주식회사한국야쿠르트 장내 균총 개선용 프로바이오틱스 조성물
TW202015712A (zh) * 2018-07-03 2020-05-01 學校法人北里研究所 用以抑制流感之重症化的抗流感病毒劑
CN109432136A (zh) * 2018-10-31 2019-03-08 张志澎 一种益生菌组合制剂及其制备方法和应用
CN110055185B (zh) * 2018-12-25 2020-12-29 江南大学 一株具有抗流感能力的短双歧杆菌及其应用
CN109576185B (zh) 2018-12-26 2020-07-03 江南大学 一种具有抗流感能力的益生菌混合制剂及其应用
CN111544456A (zh) * 2019-05-15 2020-08-18 农绍汉 一种益生菌配方及其应用
CN110051702A (zh) * 2019-06-06 2019-07-26 广东才俊创展商务服务有限公司 一种防治手足口病、流感的益生菌配方
KR102328744B1 (ko) * 2019-10-08 2021-11-22 한국식품연구원 락토바실러스 플란타럼 균주를 유효성분으로 포함하는 호흡기 질환 개선용 조성물
CN110946990B (zh) * 2019-12-16 2023-05-23 天津瑞普生物技术股份有限公司 一种禽用呼吸道微生态喷雾制剂及其应用
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用
CN112056399A (zh) * 2020-06-28 2020-12-11 武汉康复得生物科技股份有限公司 一种增强免疫力的益生菌组合物及其应用
CN116615212A (zh) * 2020-11-12 2023-08-18 生物合成公司 合生素组合物
TW202302128A (zh) * 2021-03-26 2023-01-16 香港中文大學 微生物提高疫苗效力的用途
CN114657100B (zh) * 2022-04-01 2023-07-25 江南大学 一株能够缓解流感病毒感染小鼠病理特征的戊糖乳杆菌及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241983B1 (en) 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
AUPN881396A0 (en) † 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
JP4064481B2 (ja) * 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 免疫賦活剤
DE69841826D1 (de) 1997-08-21 2010-09-23 New Zealand Dairy Board Immunitätsteigernde milchsäurebakterien
EP0904784A1 (en) † 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
NL1010770C2 (nl) † 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
JP2003535903A (ja) 2000-06-19 2003-12-02 ミューコプロテック・プロプライエタリー・リミテッド プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
FI110668B (fi) 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
GB2369777B (en) 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
DE20202562U1 (de) * 2002-02-19 2002-05-23 Orthomol Pharmazeutische Vertr Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
US20050074442A1 (en) 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
MXPA05002127A (es) 2002-07-22 2005-09-30 Agtech Products Inc Cepas de lactobacillus y usos de los mismos.
US8168171B2 (en) 2004-08-05 2012-05-01 Probiotical S.P.A. Folic acid producing bifidobacterium bacterial strains, formulations and use thereof
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
EP2269465A1 (en) 2006-05-03 2011-01-05 Probiotical S.p.a. Compositions comprising Bifidobacterium adolescentis
ITMI20072260A1 (it) 2007-12-03 2009-06-04 Anidral Srl Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115025132A (zh) * 2022-06-09 2022-09-09 康永波 一种合生元组合物及其制备方法和应用
CN115025132B (zh) * 2022-06-09 2024-01-30 康永波 一种合生元组合物及其制备方法和应用

Also Published As

Publication number Publication date
KR20070089130A (ko) 2007-08-30
US20080107634A1 (en) 2008-05-08
ES2329390T5 (es) 2013-02-11
EP1773361B1 (en) 2009-07-15
RU2007106038A (ru) 2008-10-27
DE602005015451D1 (de) 2009-08-27
HK1110510A1 (en) 2008-07-18
DK1773361T3 (da) 2009-11-16
PL1773361T5 (pl) 2012-12-31
DK1773361T4 (da) 2012-10-15
PL1773361T3 (pl) 2010-05-31
JP2008520640A (ja) 2008-06-19
RU2418063C2 (ru) 2011-05-10
US9233130B2 (en) 2016-01-12
KR101228608B1 (ko) 2013-02-01
BRPI0517273A (pt) 2008-10-07
CN101031313B (zh) 2010-06-16
BRPI0517273B8 (pt) 2021-05-25
PT1773361E (pt) 2009-10-22
BRPI0517273B1 (pt) 2020-11-03
WO2006054135A1 (en) 2006-05-26
EP1773361A1 (en) 2007-04-18
CN101031313A (zh) 2007-09-05
ES2329390T3 (es) 2009-11-25
EP1773361B2 (en) 2012-09-26

Similar Documents

Publication Publication Date Title
ITMI20042189A1 (it) Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
BRPI0616962B8 (pt) uso de lactobacillus para o tratamento de doenças autoimunes
BR112014004444A2 (pt) composições e métodos que compreendem uma variante de enzima lipolítica
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
BR112015030389A2 (pt) uso de i) uma fonte de proteína, ii) um prebiótico e iii) um probiótico para a fabricação de uma composição nutricional para o tratamento ou a prevenção de infecção em um indivíduo alérgico
EA200701820A1 (ru) Применение диосметиновых соединений при лечении и профилактике тромботических патологий
ECSP077238A (es) Composiciones para entrega de drogas altamente solubles en agua
MX2009009207A (es) Metodos y composiciones para normalizar las secreciones de glandulas meibomianas.
NO20092639L (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
MX348797B (es) Microorganismos probioticos como agentes activos para mejorar el brillo de la tez de la piel.
EA200900613A1 (ru) Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
NZ594814A (en) Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent
NZ617196A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
BR112014014410A2 (pt) composições e métodos que compreendem uma variante de enzima lipolítica
CL2008003407A1 (es) Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1.
MY144318A (en) Methods of treating hiv infection.
MA33428B1 (fr) Agonistes du gpr119
ATE530544T1 (de) Benzyl-substituierte positive allosterische chinolon-m1-rezeptormodulatoren
MY147247A (en) Organic compounds and their uses
MY155299A (en) Oral dosage composition
BRPI0509053A (pt) composição farmacêutica anidra e uso de um agente siliconado e de uma composição
BRPI0819323B8 (pt) composição à base de bactéria probiótica em associação com uma prebiótica e uso da mesma na prevenção e/ou tratamento de patologias respiratórias e/ou infecções e no aperfeiçoamento de funcionalidade intestinal
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
DE602005020639D1 (de) Zusammensetzung aus milchsäure und lactoferrin